News Sentiment

PRE sentiment intelligence

Prenetics Global Ltd news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 41 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Diagnostics & Research Read-through group
Latest close 17.86 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

80/100 classification confidence.

Company focus 41

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

+5.5% over one week, -17.4% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

Prenetics Global (NASDAQ:PRE) Price Target Raised to $40.00

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 80/100 classification
One-week reaction 5.5% Price confirming higher
Trend fit Trend active -17.4% over four weeks
Fair value 99.5% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 21
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 41
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 23
simplywall.st 3
TradingView 3
TradingKey 2
MT Newswires 2
GlobeNewswire 2
MarketBeat 1
Market source 1

Event Lens

What the news is about

Classified themes
Market update 23
Earnings 11
Deals and strategy 4
Analyst action 1
Macro sensitivity 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 41
Stock Titan Direct company coverage

[6-K] Prenetics Global Ltd Current Report (Foreign Issuer) | PRE SEC Filing - Form 6-K

Prenetics Global Limited announced the closing of a $1 billion growth financing arrangement with General Catalyst’s Customer Value Fund to scale its IM8 wellness brand. This non-dilutive financing will fund up to 70% of IM8's marketing spend, with repayment tied to the revenue ge

Tone
Positive 74/100
Event
Earnings
Published
14 Jul 2026 17:12
Source
Stock Titan
Market source Direct company coverage

Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF)

Prenetics Global Limited's AI-native wellness brand, IM8, co-founded by David Beckham, has secured $1 billion in growth financing from General Catalyst's Customer Value Fund (CVF). This non-dilutive arrangement will fund up to 70% of IM8's marketing spend, allowing Prenetics to a

Tone
Positive 86/100
Event
Market update
Published
14 Jul 2026 13:35
Source
Market source
Stock Titan Direct company coverage

Prenetics Global Ltd (PRE) CFO of IM8 (US) LLC reports 56,851 RSUs

Brian J. Rosin, CFO of IM8 (US) LLC, an officer of Prenetics Global Ltd (PRE), has reported beneficial ownership of 56,851 Restricted Stock Units (RSUs) under the company's 2022 Share Incentive Plan. These RSUs represent a contingent right to receive Class A Ordinary Shares upon

Tone
Neutral 50/100
Event
Market update
Published
10 Jul 2026 18:40
Source
Stock Titan
Stock Titan Direct company coverage

Prenetics Global (PRE) director receives 2,000 shares from vested RSUs

Prenetics Global director Hudson Blake Leogrande acquired 2,000 Class A Ordinary Shares through the settlement of vested Restricted Stock Units (RSUs) from the company's 2022 Share Incentive Plan. This transaction is considered routine equity compensation, not an open-market purc

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 11:10
Source
Stock Titan
Stock Titan Direct company coverage

Insighta 2025 results added to Prenetics (PRE) annual report amendment

Prenetics Global Limited filed an amended annual report (Form 20-F/A) to include the audited 2025 financial statements of its equity-method investee, Insighta Holdings Limited. This amendment was required because Insighta met significance thresholds under SEC Regulation S-X Rule

Tone
Positive 66/100
Event
Earnings
Published
02 Jul 2026 12:10
Source
Stock Titan
TradingKey Direct company coverage

Prenetics Global Ltd (PRE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Prenetics Global Ltd (PRE), detailing its financial performance by region. As of the stated update, specific data for business segments and profit contributions are not yet disclosed by the company. The regional revenue distribution s

Tone
Negative 39/100
Event
Earnings
Published
18 Jun 2026 04:40
Source
TradingKey
Stock Titan Direct company coverage

Prenetics Global (PRE) director’s entity converts 15,873 RSUs into Class A shares

Prenetics Global Ltd. director Cheng Yin Pan, through M13 Capital Management Holdings Limited, converted 15,873 vested Restricted Stock Units (RSUs) into Class A Ordinary Shares on June 15, 2026. This transaction increased M13 Capital's indirect holdings to 59,051 Class A Ordinar

Tone
Neutral 50/100
Event
Market update
Published
16 Jun 2026 13:09
Source
Stock Titan
Stock Titan Direct company coverage

Prenetics Global (PRE) director exercises and settles RSUs into shares

Prenetics Global director David Vanderveen exercised and settled 6,944 Restricted Stock Units (RSUs) into Class A Ordinary Shares on June 15, 2026, as part of his departure from the board. These RSUs were granted under the company's 2022 Share Incentive Plan, and any unvested uni

Tone
Neutral 50/100
Event
Market update
Published
16 Jun 2026 12:09
Source
Stock Titan
Stock Titan Direct company coverage

24,004 RSUs vest for Prenetics (PRE) director Hudson Blake

Prenetics Global Ltd (PRE) director Leogrande Hudson Blake reported an initial holding of 24,004 Restricted Stock Units (RSUs), which vested on June 4, 2026. These RSUs will be settled in Class A Ordinary Shares through 12 equal monthly installments starting July 4, 2026, conting

Tone
Neutral 50/100
Event
Market update
Published
15 Jun 2026 16:40
Source
Stock Titan
Stock Titan Direct company coverage

David Beckham-backed IM8 nears $200M run-rate as Prenetics posts record quarter

Prenetics (NASDAQ: PRE) reported record Q1 2026 results, driven by its IM8 brand which contributed $33.8 million in revenue, a 23% sequential and nearly 6x year-over-year increase. The company raised its full-year 2026 IM8 revenue guidance to $190–$210 million, with May 2026 IM8

Tone
Positive 65/100
Event
Earnings
Published
12 Jun 2026 01:41
Source
Stock Titan
Stock Titan Direct company coverage

Prenetics Global (PRE) director lists indirect share and warrant holdings

Prenetics Global director Cheng Yin Pan has amended his insider disclosures to detail indirect holdings through M13 Capital Management Holdings Limited, a company he wholly owns. These holdings include 43,178 Class A Ordinary Shares, 48,816 underlying warrant shares (after a 1-fo

Tone
Neutral 50/100
Event
Market update
Published
28 May 2026 14:40
Source
Stock Titan
Stock Titan Direct company coverage

Prenetics Global (PRE) grants CFO 91,629 restricted stock units

Prenetics Global Ltd (PRE) has granted its Chief Financial Officer, Lo Hoi Chun, 91,629 Restricted Stock Units (RSUs) under the company's 2022 Share Incentive Plan. These RSUs will vest over time, starting May 19, 2026, and extending through April 19, 2027, subject to continued s

Tone
Neutral 50/100
Event
Market update
Published
20 May 2026 12:40
Source
Stock Titan
Stock Titan Direct company coverage

Prenetics (NASDAQ: PRE) hires Brian Rosin as IM8 CFO amid rapid growth

Prenetics Global Limited (NASDAQ: PRE) has appointed Brian J. Rosin as the Chief Financial Officer of its premium health and longevity brand, IM8. Rosin brings nearly two decades of financial leadership in consumer e-commerce and wellness subscriptions to support IM8's rapid glob

Tone
Positive 73/100
Event
Market update
Published
15 May 2026 10:10
Source
Stock Titan
Stock Titan Direct company coverage

David Beckham-backed IM8 hires veteran CFO for 2026 $190M–$210M push

Prenetics (NASDAQ: PRE), the parent company of IM8, a health and longevity brand co-founded by David Beckham, has appointed Brian J. Rosin as its U.S. Chief Financial Officer. Rosin will lead finance, capital allocation, and investor relations, bringing nearly two decades of expe

Tone
Positive 66/100
Event
Market update
Published
14 May 2026 23:09
Source
Stock Titan
Stock Titan Direct company coverage

Prenetics (NASDAQ: PRE) surges on IM8 growth, higher 2026 guidance and buybacks

Prenetics Global (NASDAQ: PRE) announced strong preliminary Q1 2026 results, driven by its IM8 premium nutrition brand, which saw significant revenue growth and improved gross margins. The company raised its full-year 2026 IM8 revenue guidance, demonstrating confidence in continu

Tone
Positive 71/100
Event
Earnings
Published
14 May 2026 12:10
Source
Stock Titan
Stock Titan Direct company coverage

Prenetics (NASDAQ: PRE) exits Bitcoin, eyes larger buybacks and IM8 growth

Prenetics Global Limited (NASDAQ: PRE) announced its decision to fully divest its approximately 510 Bitcoin holdings by May 14, 2026, expecting around $40 million in gross proceeds. This move will boost its cash reserves from $112 million to an estimated $145-$150 million and all

Tone
Positive 77/100
Event
Balance sheet
Published
09 May 2026 19:09
Source
Stock Titan
Stock Titan Direct company coverage

Prenetics will post Q1 results May 14, then take analyst questions

Prenetics (NASDAQ: PRE) announced it will release its first-quarter 2026 financial results on May 14, 2026, before market open. The company will host an earnings conference call and webcast on the same day at 8:30 a.m. Eastern Time, followed by a Q&A session with analysts. This a

Tone
Positive 60/100
Event
Earnings
Published
09 May 2026 08:40
Source
Stock Titan
Stock Titan Direct company coverage

Genetel and Michael Yang report 3.3% stake in Prenetics Global (PRE)

Genetel Bioventures Ltd and Michael Yang Mengsu have jointly reported a beneficial ownership of 488,857 Class A Ordinary Shares in Prenetics Global Ltd (PRE), representing a 3.3% stake. This information was disclosed in an amended passive investment filing (SCHEDULE 13G/A) with t

Tone
Neutral 50/100
Event
Deals and strategy
Published
22 Apr 2026 16:09
Source
Stock Titan
Stock Titan Direct company coverage

PRE SEC Filings - Prenetics Ltd 10-K, 10-Q, 8-K Forms

This article provides an overview of Prenetics Global Limited's SEC filings, including 6-K reports detailing material corporate updates, financial results, and press releases. It highlights specific filings such as preliminary prospectus supplements for share offerings, press rel

Tone
Negative 35/100
Event
Earnings
Published
20 Apr 2026 10:10
Source
Stock Titan
Bitget Direct company coverage

According to the latest filing by the U.S. Securities and Exchange Commission (SEC), existing shareholders of Prenetics Global Ltd have submitted an offering application, planning to sell up to 2.36 million Class A ordinary shares.

Existing shareholders of Prenetics Global Ltd have filed an application with the SEC to sell up to 2.36 million Class A ordinary shares. The sale is being led by these selling shareholders, and Prenetics Global Ltd will not receive any proceeds from this transaction. This informa

Tone
Negative 37/100
Event
Market update
Published
02 Apr 2026 08:10
Source
Bitget